These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 28725968)

  • 21. Structural requirements for activation of latent platelet-derived growth factor CC by tissue plasminogen activator.
    Fredriksson L; Ehnman M; Fieber C; Eriksson U
    J Biol Chem; 2005 Jul; 280(29):26856-62. PubMed ID: 15911618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
    Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
    Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke.
    Liu H; Wang Y; Xiao Y; Hua Z; Cheng J; Jia J
    Transl Stroke Res; 2016 Jun; 7(3):209-19. PubMed ID: 27018013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of NLRP3 attenuates hemorrhagic transformation after delayed rtPA treatment in thromboembolic stroke rats: Involvement of neutrophil recruitment.
    Guo Z; Yu S; Chen X; Zheng P; Hu T; Duan Z; Liu X; Liu Q; Ye R; Zhu W; Liu X
    Brain Res Bull; 2018 Mar; 137():229-240. PubMed ID: 29258866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI evaluation of BBB disruption after adjuvant AcSDKP treatment of stroke with tPA in rat.
    Ding G; Zhang Z; Chopp M; Li L; Zhang L; Li Q; Wei M; Jiang Q
    Neuroscience; 2014 Jun; 271():1-8. PubMed ID: 24769225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bryostatin extends tPA time window to 6 h following middle cerebral artery occlusion in aged female rats.
    Tan Z; Lucke-Wold BP; Logsdon AF; Turner RC; Tan C; Li X; Hongpaison J; Alkon DL; Simpkins JW; Rosen CL; Huber JD
    Eur J Pharmacol; 2015 Oct; 764():404-412. PubMed ID: 26189021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of connexin43 in hemorrhagic transformation after thrombolysis in vivo and in vitro.
    Yang X; Chu H; Tang Y; Dong Q
    Neuroscience; 2016 Aug; 329():54-65. PubMed ID: 27138645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rosiglitazone ameliorates tissue plasminogen activator-induced brain hemorrhage after stroke.
    Li Y; Zhu ZY; Lu BW; Huang TT; Zhang YM; Zhou NY; Xuan W; Chen ZA; Wen DX; Yu WF; Li PY
    CNS Neurosci Ther; 2019 Dec; 25(12):1343-1352. PubMed ID: 31756041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia.
    Li Q; Han X; Lan X; Hong X; Li Q; Gao Y; Luo T; Yang Q; Koehler RC; Zhai Y; Zhou J; Wang J
    Neurobiol Dis; 2017 Dec; 108():173-182. PubMed ID: 28830843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke.
    Simão F; Ustunkaya T; Clermont AC; Feener EP
    Blood; 2017 Apr; 129(16):2280-2290. PubMed ID: 28130211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit.
    Polavarapu R; Gongora MC; Yi H; Ranganthan S; Lawrence DA; Strickland D; Yepes M
    Blood; 2007 Apr; 109(8):3270-8. PubMed ID: 17170123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative MRI reveals the elderly ischemic brain is susceptible to increased early blood-brain barrier permeability following tissue plasminogen activator related to claudin 5 and occludin disassembly.
    Kaur J; Tuor UI; Zhao Z; Barber PA
    J Cereb Blood Flow Metab; 2011 Sep; 31(9):1874-85. PubMed ID: 21610723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. YangXueQingNaoWan attenuated blood brain barrier disruption after thrombolysis with tissue plasminogen activator in ischemia stroke.
    Yao SQ; Ye Y; Li Q; Wang XY; Yan L; Huo XM; Pan CS; Fu Y; Liu J; Han JY
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117024. PubMed ID: 37572928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.
    Wang W; Li M; Wang Y; Li Q; Deng G; Wan J; Yang Q; Chen Q; Wang J
    Mol Neurobiol; 2016 Dec; 53(10):7028-7036. PubMed ID: 26671619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator.
    Jin R; Yang G; Li G
    Neurobiol Dis; 2010 Jun; 38(3):376-85. PubMed ID: 20302940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Annexin A2 Plus Low-Dose Tissue Plasminogen Activator Combination Attenuates Cerebrovascular Dysfunction After Focal Embolic Stroke of Rats.
    Fan X; Jiang Y; Yu Z; Liu Q; Guo S; Sun X; van Leyen K; Ning M; Gao X; Lo EH; Wang X
    Transl Stroke Res; 2017 Dec; 8(6):549-559. PubMed ID: 28580536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke.
    Wang C; Huang R; Li C; Lu M; Emanuele M; Zhang ZG; Chopp M; Zhang L
    Stroke; 2019 Dec; 50(12):3600-3608. PubMed ID: 31587657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.
    Yepes M; Sandkvist M; Moore EG; Bugge TH; Strickland DK; Lawrence DA
    J Clin Invest; 2003 Nov; 112(10):1533-40. PubMed ID: 14617754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Albumin ameliorates tissue plasminogen activator-mediated blood-brain barrier permeability and ischemic brain injury in rats.
    Tang J; Li YJ; Mu J; Li Q; Yang DY; Xie P
    Neurol Res; 2009 Mar; 31(2):189-94. PubMed ID: 19298760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole body hypothermia extends tissue plasminogen activator treatment window in the rat model of embolic stroke.
    Hassanipour M; Zarisfi M; Ehsani V; Allahtavakoli M
    Life Sci; 2020 Sep; 256():117450. PubMed ID: 32087233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.